Oncopeptides AB (publ) (ONPPF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 106.48 Million SEK | 2905.56% |
| 2022 | 3.54 Million SEK | 10.51% |
| 2021 | 3.2 Million SEK | -53.73% |
| 2020 | 6.92 Million SEK | -15.94% |
| 2019 | 8.24 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 113.64 Million SEK | 6.72% |
| 2024 Q2 | 114.88 Million SEK | 1.09% |
| 2023 Q1 | 4.41 Million SEK | 24.58% |
| 2023 Q2 | 109.17 Million SEK | 2373.36% |
| 2023 FY | 106.48 Million SEK | 2905.56% |
| 2023 Q3 | 107.97 Million SEK | -1.09% |
| 2023 Q4 | 106.48 Million SEK | -1.38% |
| 2022 Q2 | 6.46 Million SEK | 1.79% |
| 2022 Q3 | 5.89 Million SEK | -8.92% |
| 2022 Q4 | 3.54 Million SEK | -39.85% |
| 2022 FY | 3.54 Million SEK | 10.51% |
| 2022 Q1 | 6.35 Million SEK | 98.16% |
| 2021 Q1 | 3.56 Million SEK | -48.49% |
| 2021 Q2 | 1.26 Million SEK | -64.47% |
| 2021 Q3 | 191 Thousand SEK | -84.94% |
| 2021 Q4 | 3.2 Million SEK | 1578.53% |
| 2021 FY | 3.2 Million SEK | -53.73% |
| 2020 Q2 | 12.77 Million SEK | 12.89% |
| 2020 Q1 | 11.31 Million SEK | 37.29% |
| 2020 FY | 6.92 Million SEK | -15.94% |
| 2020 Q4 | 6.92 Million SEK | -29.94% |
| 2020 Q3 | 9.89 Million SEK | -22.59% |
| 2019 Q2 | 4.1 Million SEK | -19.3% |
| 2019 FY | 8.24 Million SEK | 0.0% |
| 2019 Q1 | 5.08 Million SEK | 0.0% |
| 2019 Q3 | 3.12 Million SEK | -23.92% |
| 2019 Q4 | 8.24 Million SEK | 164.2% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -64750.035% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -8569.031% |
| Evofem Biosciences, Inc. | 8000.00 USD | -1330987.5% |
| GB Sciences, Inc. | 322 Thousand USD | -32970.497% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -62089.453% |
| Zenith Capital Corp. | 4456.00 USD | -2389644.165% |
| Agentix Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| ContraFect Corporation | 2.21 Million USD | -4718.416% |
| CSL Limited | 11.23 Billion USD | 99.053% |
| CytoDyn Inc. | 141 Thousand USD | -75422.695% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -424.257% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -181488.281% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -71074.489% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -5965.98% |
| SQZ Biotechnologies Company | 20.9 Million USD | -409.288% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -1931812.192% |
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| Mesoblast Limited | 100.29 Million USD | -6.174% |
| Marizyme, Inc. | 667.12 Thousand USD | -15861.98% |
| Genus plc | 228.2 Million USD | 53.336% |
| Pharming Group N.V. | 166.1 Million USD | 35.892% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -7490.307% |
| IMV Inc. | 27.39 Million USD | -288.659% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -1862.359% |
| MultiCell Technologies, Inc. | 36.43 USD | -292305691.93% |
| ONE Bio Corp. | 592.19 Thousand USD | -17881.655% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -91.482% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -4683.783% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -420813.87% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -5509.102% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| Enzolytics Inc. | - USD | -Infinity% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -593.546% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Genscript Biotech Corporation | 287.12 Million USD | 62.913% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -84211.412% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -46341.858% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -1188.565% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -19101.031% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -39987.714% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 150 Thousand USD | -70891.333% |
| Resverlogix Corp. | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -46260.981% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 1064.00 USD | -10008076.692% |
| LadRx Corporation | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -71074.489% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 445 Thousand USD | -23829.663% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -133008.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -1261.733% |
| SYBLEU INC | 300 Thousand USD | -35395.667% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -28754.434% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -1206.589% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -23201.313% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -9072.007% |
| PureTech Health plc | 18.25 Million USD | -483.49% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -70891.333% |
| IXICO plc | 275 Thousand USD | -38622.545% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -799.459% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -304.755% |
| CSL Limited | 11.23 Billion USD | 99.053% |
| Cellectis S.A. | 36.21 Million USD | -194.072% |